Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Fifteen Years of the J Project.

Maródi L; J Project study group.

J Clin Immunol. 2019 May;39(4):363-369. doi: 10.1007/s10875-019-00633-4. Epub 2019 May 17. No abstract available.

PMID:
31102035
2.

Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies.

Paris K, Haddad E, Borte M, Brodszki N, Dérfalvi B, Maródi L, Hussain I, Darter A, Engl W, Leibl H, McCoy B, Yel L.

Immunotherapy. 2019 Apr;11(5):397-406. doi: 10.2217/imt-2018-0088. Epub 2019 Jan 9.

3.

[Editor's commentary. Interdisciplinary immunodeficiency: a novel approach to understanding primary immunodeficiency disorders].

Maródi L.

Orv Hetil. 2018 Jun;159(23):895-897. doi: 10.1556/650.2018.31111. Hungarian. No abstract available.

PMID:
29860886
4.

[Cutaneous manifestations in primary immunodeficiency diseases].

Bojtor AE, Sárdy M, Maródi L.

Orv Hetil. 2018 Jun;159(23):937-947. doi: 10.1556/650.2018.30994. Review. Hungarian.

PMID:
29860885
5.

From Ignác Semmelweis to Primary Immunodeficiencies: a Bicentenary Commemoration.

Maródi L.

J Clin Immunol. 2018 Apr;38(3):247-250. doi: 10.1007/s10875-018-0495-x. Epub 2018 Apr 13. No abstract available.

PMID:
29654497
6.

Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study.

Germain DP, Brand E, Burlina A, Cecchi F, Garman SC, Kempf J, Laney DA, Linhart A, Maródi L, Nicholls K, Ortiz A, Pieruzzi F, Shankar SP, Waldek S, Wanner C, Jovanovic A.

Mol Genet Genomic Med. 2018 Apr 12. doi: 10.1002/mgg3.389. [Epub ahead of print]

7.

[Nobel Prize for the discoveries of genetic mechanisms controlling the circadian rythm].

Maródi L.

Orv Hetil. 2018 Feb;159(6):239. doi: 10.1556/650.2018.HO2590. Hungarian. No abstract available.

PMID:
29400101
8.

Inborn errors of T cell immunity underlying autoimmune diseases.

Maródi L.

Expert Rev Clin Immunol. 2017 Feb;13(2):97-99. doi: 10.1080/1744666X.2017.1256204. Epub 2016 Nov 18. No abstract available.

PMID:
27801603
9.

Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies.

Borte M, Kriván G, Derfalvi B, Maródi L, Harrer T, Jolles S, Bourgeois C, Engl W, Leibl H, McCoy B, Gelmont D, Yel L.

Clin Exp Immunol. 2017 Jan;187(1):146-159. doi: 10.1111/cei.12866. Epub 2016 Oct 18.

10.

Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, Ouachée-Chardin M, Fouyssac F, Girisha KM, Etzioni A, Van Montfrans J, Camcioglu Y, Kerns LA, Belohradsky B, Blanche S, Bousfiha A, Rodriguez-Gallego C, Meyts I, Kisand K, Reichenbach J, Renner ED, Rosenzweig S, Grimbacher B, van de Veerdonk FL, Traidl-Hoffmann C, Picard C, Marodi L, Morio T, Kobayashi M, Lilic D, Milner JD, Holland S, Casanova JL, Puel A; International STAT1 Gain-of-Function Study Group.

Blood. 2016 Jun 23;127(25):3154-64. doi: 10.1182/blood-2015-11-679902. Epub 2016 Apr 25.

11.

Investigation of Skin Barrier Functions and Allergic Sensitization in Patients with Hyper-IgE Syndrome.

Mócsai G, Gáspár K, Dajnoki Z, Tóth B, Gyimesi E, Bíró T, Maródi L, Szegedi A.

J Clin Immunol. 2015 Oct;35(7):681-8. doi: 10.1007/s10875-015-0200-2. Epub 2015 Oct 9.

PMID:
26453584
12.

Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.

Wolska-Kuśnierz B, Gregorek H, Chrzanowska K, Piątosa B, Pietrucha B, Heropolitańska-Pliszka E, Pac M, Klaudel-Dreszler M, Kostyuchenko L, Pasic S, Marodi L, Belohradsky BH, Čižnár P, Shcherbina A, Kilic SS, Baumann U, Seidel MG, Gennery AR, Syczewska M, Mikołuć B, Kałwak K, Styczyński J, Pieczonka A, Drabko K, Wakulińska A, Gathmann B, Albert MH, Skarżyńska U, Bernatowska E; Inborn Errors Working Party of the Society for European Blood and Marrow Transplantation and the European Society for Immune Deficiencies.

J Clin Immunol. 2015 Aug;35(6):538-49. doi: 10.1007/s10875-015-0186-9. Epub 2015 Aug 14.

PMID:
26271390
13.

The Evolving View of IL-17-Mediated Immunity in Defense Against Mucocutaneous Candidiasis in Humans.

Soltész B, Tóth B, Sarkadi AK, Erdős M, Maródi L.

Int Rev Immunol. 2015;34(4):348-63. doi: 10.3109/08830185.2015.1049345. Review.

PMID:
26154078
14.

Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells.

Rieber N, Singh A, Öz H, Carevic M, Bouzani M, Amich J, Ost M, Ye Z, Ballbach M, Schäfer I, Mezger M, Klimosch SN, Weber AN, Handgretinger R, Krappmann S, Liese J, Engeholm M, Schüle R, Salih HR, Marodi L, Speckmann C, Grimbacher B, Ruland J, Brown GD, Beilhack A, Loeffler J, Hartl D.

Cell Host Microbe. 2015 Apr 8;17(4):507-14. doi: 10.1016/j.chom.2015.02.007. Epub 2015 Mar 12.

15.

Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.

Turley AJ, Gathmann B, Bangs C, Bradbury M, Seneviratne S, Gonzalez-Granado LI, Hackett S, Kutukculer N, Alachkar H, Hambleton S, Ritterbusch H, Kralickova P, Marodi L, Seidel MG, Dueckers G, Roesler J, Huissoon A, Baxendale H, Litzman J, Arkwright PD.

J Clin Immunol. 2015 Feb;35(2):199-205. doi: 10.1007/s10875-015-0137-5. Epub 2015 Feb 8.

PMID:
25663093
16.

DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.

Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, Kostyuchenko L, Genel F, Kütükcüler N, Karaca N, Gonzalez-Granado L, Abbott J, Al-Zahrani D, Rezaei N, Baz Z, Thiel J, Ehl S, Marodi L, Orange JS, Sawalle-Belohradsky J, Keles S, Holland SM, Sanal Ö, Ayvaz DC, Tezcan I, Al-Mousa H, Alsum Z, Hawwari A, Metin A, Matthes-Martin S, Hönig M, Schulz A, Picard C, Barlogis V, Gennery A, Ifversen M, van Montfrans J, Kuijpers T, Bredius R, Dückers G, Al-Herz W, Pai SY, Geha R, Notheis G, Schwarze CP, Tavil B, Azik F, Bienemann K, Grimbacher B, Heinz V, Gaspar HB, Aydin R, Hagl B, Gathmann B, Belohradsky BH, Ochs HD, Chatila T, Renner ED, Su H, Freeman AF, Engelhardt K, Albert MH; inborn errors working party of EBMT.

J Clin Immunol. 2015 Feb;35(2):189-98. doi: 10.1007/s10875-014-0126-0. Epub 2015 Jan 28.

PMID:
25627830
17.

Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.

Tóth B, Soltész B, Gyimesi E, Csorba G, Veres Á, Lányi Á, Kovács G, Maródi L, Erdős M.

J Clin Immunol. 2015 Jan;35(1):26-31. doi: 10.1007/s10875-014-0117-1. Epub 2014 Dec 10.

PMID:
25491288
18.

A novel large deletion and single nucleotide insertion in the Wiskott-Aldrich syndrome protein gene.

Gulácsy V, Soltész B, Petrescu C, Bataneant M, Gyimesi E, Serban M, Maródi L, Tóth B.

Eur J Haematol. 2015 Jul;95(1):93-8. doi: 10.1111/ejh.12424. Epub 2014 Oct 18.

PMID:
25082437
19.

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, Modlich U, Beier R, Göhring G, Steinemann D, Fronza R, Ball CR, Haemmerle R, Naundorf S, Kühlcke K, Rose M, Fraser C, Mathias L, Ferrari R, Abboud MR, Al-Herz W, Kondratenko I, Maródi L, Glimm H, Schlegelberger B, Schambach A, Albert MH, Schmidt M, von Kalle C, Klein C.

Sci Transl Med. 2014 Mar 12;6(227):227ra33. doi: 10.1126/scitranslmed.3007280.

20.

Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.

Sarkadi AK, Taskó S, Csorba G, Tóth B, Erdős M, Maródi L.

J Clin Immunol. 2014 Feb;34(2):181-93. doi: 10.1007/s10875-014-9987-5. Epub 2014 Feb 4.

PMID:
24493573
21.

Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis.

Mócsai G, Gáspár K, Nagy G, Irinyi B, Kapitány A, Bíró T, Gyimesi E, Tóth B, Maródi L, Szegedi A.

Br J Dermatol. 2014 Mar;170(3):617-24. doi: 10.1111/bjd.12743.

PMID:
24251354
22.

Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.

Wolff AS, Sarkadi AK, Maródi L, Kärner J, Orlova E, Oftedal BE, Kisand K, Oláh E, Meloni A, Myhre AG, Husebye ES, Motaghedi R, Perheentupa J, Peterson P, Willcox N, Meager A.

J Clin Immunol. 2013 Nov;33(8):1341-8. doi: 10.1007/s10875-013-9938-6. Epub 2013 Oct 26.

PMID:
24158785
23.

High-content cytometry and transcriptomic biomarker profiling of human B-cell activation.

Hennig C, Ilginus C, Boztug K, Skokowa J, Marodi L, Szaflarska A, Sass M, Pignata C, Kilic SS, Caragol I, Baumann U, Klein C, Welte K, Hansen G.

J Allergy Clin Immunol. 2014 Jan;133(1):172-80.e1-10. doi: 10.1016/j.jaci.2013.06.047. Epub 2013 Sep 5. Erratum in: J Allergy Clin Immunol. 2014 Apr;133(4):1232.

PMID:
24012209
24.

Novel dedicator of cytokinesis 8 mutations identified by multiplex ligation-dependent probe amplification.

Tóth B, Pistár Z, Csorba G, Balogh I, Kovács T, Erdős M, Maródi L.

Eur J Haematol. 2013 Oct;91(4):369-75. doi: 10.1111/ejh.12173. Epub 2013 Aug 20.

PMID:
23859592
25.

Analysis of lyso-globotriaosylsphingosine in dried blood spots.

Johnson B, Mascher H, Mascher D, Legnini E, Hung CY, Dajnoki A, Chien YH, Maródi L, Hwu WL, Bodamer OA.

Ann Lab Med. 2013 Jul;33(4):274-8. doi: 10.3343/alm.2013.33.4.274. Epub 2013 Jun 24.

26.

New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.

Soltész B, Tóth B, Shabashova N, Bondarenko A, Okada S, Cypowyj S, Abhyankar A, Csorba G, Taskó S, Sarkadi AK, Méhes L, Rozsíval P, Neumann D, Chernyshova L, Tulassay Z, Puel A, Casanova JL, Sediva A, Litzman J, Maródi L.

J Med Genet. 2013 Sep;50(9):567-78. doi: 10.1136/jmedgenet-2013-101570. Epub 2013 May 24.

27.

The spread of the J Project.

Horváth Z, Rezaei N, Reisli I, Tuzankina I, Otarbayev N, Popandopulo P, Maródi L.

J Clin Immunol. 2013 Aug;33(6):1037-42. doi: 10.1007/s10875-013-9905-2. Epub 2013 May 19. Review.

PMID:
23686437
28.

Molecular genetic characterization of novel sphingomyelin phosphodiesterase 1 mutations causing niemann-pick disease.

Tóth B, Erdős M, Székely A, Ritli L, Bagossi P, Sümegi J, Maródi L.

JIMD Rep. 2012;3:125-9. doi: 10.1007/8904_2011_80. Epub 2011 Sep 27.

29.

Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.

Maródi L, Cypowyj S, Tóth B, Chernyshova L, Puel A, Casanova JL.

J Allergy Clin Immunol. 2012 Nov;130(5):1019-27. doi: 10.1016/j.jaci.2012.09.011. Epub 2012 Oct 3. Review.

30.

Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.

Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL.

Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):616-22. doi: 10.1097/ACI.0b013e328358cc0b. Review.

31.

IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients.

Weller S, Bonnet M, Delagreverie H, Israel L, Chrabieh M, Maródi L, Rodriguez-Gallego C, Garty BZ, Roifman C, Issekutz AC, Zitnik SE, Hoarau C, Camcioglu Y, Vasconcelos J, Rodrigo C, Arkwright PD, Cerutti A, Meffre E, Zhang SY, Alcais A, Puel A, Casanova JL, Picard C, Weill JC, Reynaud CA.

Blood. 2012 Dec 13;120(25):4992-5001. doi: 10.1182/blood-2012-07-440776. Epub 2012 Sep 21.

32.

Immunity to infection in IL-17-deficient mice and humans.

Cypowyj S, Picard C, Maródi L, Casanova JL, Puel A.

Eur J Immunol. 2012 Sep;42(9):2246-54. doi: 10.1002/eji.201242605. Review.

33.

Herpes in STAT1 gain-of-function mutation [corrected].

Tóth B, Méhes L, Taskó S, Szalai Z, Tulassay Z, Cypowyj S, Casanova JL, Puel A, Maródi L.

Lancet. 2012 Jun 30;379(9835):2500. doi: 10.1016/S0140-6736(12)60365-1. No abstract available. Erratum in: Lancet. 2012 Sep 1;380(9844):806.

PMID:
22748593
34.

The cognitive profile of type 1 Gaucher disease patients.

Biegstraaten M, Wesnes KA, Luzy C, Petakov M, Mrsic M, Niederau C, Giraldo P, Hughes D, Mehta A, Mengel KE, Hollak CE, Maródi L, van Schaik IN.

J Inherit Metab Dis. 2012 Nov;35(6):1093-9. doi: 10.1007/s10545-012-9460-7. Epub 2012 Feb 21.

35.

[Enzyme replacement therapy for Gaucher disease introduced in late adulthood].

Juhász P, Tóth B, Maródi L, Erdos M.

Orv Hetil. 2012 Feb 19;153(7):264-70. doi: 10.1556/OH.2012.29281. Hungarian.

PMID:
22318527
36.

The creation and progress of the J Project in Eastern and Central Europe.

Maródi L; J Project Study Group.

Ann N Y Acad Sci. 2011 Nov;1238:65-73. doi: 10.1111/j.1749-6632.2011.06247.x.

PMID:
22129054
37.

Hepatic abscess as the single manifestation of X-linked chronic granulomatous disease.

Székely A, Péter M Jr, Erdos M, Maródi L.

Pediatr Blood Cancer. 2012 May;58(5):828-9. doi: 10.1002/pbc.23362. Epub 2011 Oct 19. No abstract available.

PMID:
22012688
38.

Phagocytosis and intracellular killing of heterogeneous vancomycin-intermediate Staphylococcus aureus strains.

Méhes L, Taskó S, Székely A, Tóth A, Ungvári E, Erdei I, Dombrádi Z, Szabó J, Maródi L.

J Med Microbiol. 2012 Feb;61(Pt 2):198-203. doi: 10.1099/jmm.0.029421-0. Epub 2011 Sep 29.

PMID:
21959204
39.

Molecular Diagnostic Challenges and Complex Management of Consecutive Twin Pregnancies in a Family with CD40 Ligand Deficiency.

Török O, Tóth B, Erdős M, Csorba G, Gyimesi E, Balogh I, Tóth Z, Maródi L.

Scand J Immunol. 2012 Feb;75(2):227-30. doi: 10.1111/j.1365-3083.2011.02644.x.

40.

Cytotoxic T lymphocytes mediate neuronal injury in patients with X-linked agammaglobulinemia and progressive neurodegenerative disease.

Tuzankina I, Kobeleva Y, Kiseleva N, Bolkov M, Reuter G, Maródi L.

Allergy. 2011 Dec;66(12):1617-8. doi: 10.1111/j.1398-9995.2011.02718.x. Epub 2011 Sep 27. No abstract available.

PMID:
21951217
41.

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation.

Warnock DG, Ortiz A, Mauer M, Linthorst GE, Oliveira JP, Serra AL, Maródi L, Mignani R, Vujkovac B, Beitner-Johnson D, Lemay R, Cole JA, Svarstad E, Waldek S, Germain DP, Wanner C; Fabry Registry.

Nephrol Dial Transplant. 2012 Mar;27(3):1042-9. doi: 10.1093/ndt/gfr420. Epub 2011 Jul 29.

42.

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.

Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, Toubiana J, Itan Y, Audry M, Nitschke P, Masson C, Toth B, Flatot J, Migaud M, Chrabieh M, Kochetkov T, Bolze A, Borghesi A, Toulon A, Hiller J, Eyerich S, Eyerich K, Gulácsy V, Chernyshova L, Chernyshov V, Bondarenko A, Grimaldo RM, Blancas-Galicia L, Beas IM, Roesler J, Magdorf K, Engelhard D, Thumerelle C, Burgel PR, Hoernes M, Drexel B, Seger R, Kusuma T, Jansson AF, Sawalle-Belohradsky J, Belohradsky B, Jouanguy E, Bustamante J, Bué M, Karin N, Wildbaum G, Bodemer C, Lortholary O, Fischer A, Blanche S, Al-Muhsen S, Reichenbach J, Kobayashi M, Rosales FE, Lozano CT, Kilic SS, Oleastro M, Etzioni A, Traidl-Hoffmann C, Renner ED, Abel L, Picard C, Maródi L, Boisson-Dupuis S, Puel A, Casanova JL.

J Exp Med. 2011 Aug 1;208(8):1635-48. doi: 10.1084/jem.20110958. Epub 2011 Jul 4.

43.

Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome.

Gulácsy V, Freiberger T, Shcherbina A, Pac M, Chernyshova L, Avcin T, Kondratenko I, Kostyuchenko L, Prokofjeva T, Pasic S, Bernatowska E, Kutukculer N, Rascon J, Iagaru N, Mazza C, Tóth B, Erdos M, van der Burg M, Maródi L; J Project Study Group.

Mol Immunol. 2011 Feb;48(5):788-92. doi: 10.1016/j.molimm.2010.11.013. Epub 2010 Dec 24.

PMID:
21185603
44.

[Subcutaneous immunoglobulin substitution and therapy].

Gulácsy V, Maródi L.

Orv Hetil. 2011 Jan 9;152(2):64-7. doi: 10.1556/OH.2011.28940. Hungarian.

PMID:
21177233
45.

Stem-cell gene therapy for the Wiskott-Aldrich syndrome.

Boztug K, Schmidt M, Schwarzer A, Banerjee PP, Díez IA, Dewey RA, Böhm M, Nowrouzi A, Ball CR, Glimm H, Naundorf S, Kühlcke K, Blasczyk R, Kondratenko I, Maródi L, Orange JS, von Kalle C, Klein C.

N Engl J Med. 2010 Nov 11;363(20):1918-27. doi: 10.1056/NEJMoa1003548.

46.

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O, Arkwright PD, McDonald D, Geha RS, Takada H, Krause JC, Creech CB, Ku CL, Ehl S, Maródi L, Al-Muhsen S, Al-Hajjar S, Al-Ghonaium A, Day-Good NK, Holland SM, Gallin JI, Chapel H, Speert DP, Rodriguez-Gallego C, Colino E, Garty BZ, Roifman C, Hara T, Yoshikawa H, Nonoyama S, Domachowske J, Issekutz AC, Tang M, Smart J, Zitnik SE, Hoarau C, Kumararatne DS, Thrasher AJ, Davies EG, Bethune C, Sirvent N, de Ricaud D, Camcioglu Y, Vasconcelos J, Guedes M, Vitor AB, Rodrigo C, Almazán F, Méndez M, Aróstegui JI, Alsina L, Fortuny C, Reichenbach J, Verbsky JW, Bossuyt X, Doffinger R, Abel L, Puel A, Casanova JL.

Medicine (Baltimore). 2010 Nov;89(6):403-25. doi: 10.1097/MD.0b013e3181fd8ec3.

47.

Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments.

Maródi L, Casanova JL.

J Allergy Clin Immunol. 2010 Nov;126(5):910-7. doi: 10.1016/j.jaci.2010.08.009. Epub 2010 Oct 12. Review.

PMID:
20943260
48.

Nijmegen breakage syndrome complicated with primary cutaneous tuberculosis.

Erdös M, Tóth B, Veres I, Kiss M, Remenyik E, Maródi L.

Pediatr Infect Dis J. 2011 Apr;30(4):359-60. doi: 10.1097/INF.0b013e3181faa941.

PMID:
20924312
49.

Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry.

Wanner C, Oliveira JP, Ortiz A, Mauer M, Germain DP, Linthorst GE, Serra AL, Maródi L, Mignani R, Cianciaruso B, Vujkovac B, Lemay R, Beitner-Johnson D, Waldek S, Warnock DG.

Clin J Am Soc Nephrol. 2010 Dec;5(12):2220-8. doi: 10.2215/CJN.04340510. Epub 2010 Sep 2.

50.

Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, Avcin T, de Boer M, Bustamante J, Condino-Neto A, Di Matteo G, He J, Hill HR, Holland SM, Kannengiesser C, Köker MY, Kondratenko I, van Leeuwen K, Malech HL, Marodi L, Nunoi H, Stasia MJ, Ventura AM, Witwer CT, Wolach B, Gallin JI.

Blood Cells Mol Dis. 2010 Oct 15;45(3):246-65. doi: 10.1016/j.bcmd.2010.07.012. Epub 2010 Aug 21. Review.

Supplemental Content

Loading ...
Support Center